Skip to main content

Formulate

Find pharma jobs. Prep for interviews like no one else can.

Browse

Jobs Companies Drugs Indications Career Advisor About

Insider Intel

Intelligence Hub Therapeutic Areas Contribute Intro Network Salary Explorer For Employers Pricing

Legal

Privacy Policy Terms of Service About Our Crawler Content Removal Your Privacy Choices

© 2026 Formulate. Pharma Jobs with Drug Intelligence.

argenx Jobs | Formulate

Jobs
argenx

argenx Jobs

Belgium - Zwijnaarde

Biotechnology

argenx is a life sciences company focused on Antibody therapies.

77 open positions at argenx

View Full Profile

Filters:Immunology ×

Medical Affairs and Evidence Generation Asset Lead –Executive Director

argenx

Posted 5d ago

Remote

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteMedical AffairsImmunologyExecutive

H-1B · 1 FY23

Medical Affairs and Evidence Generation Asset Lead – Executive Director

argenx

Posted 5d ago

Remote

$175K - $377K

Full-time

Director, Regulatory Affairs

argenx

Posted 5d ago

Remote

$212K - $292K

Full-time

Associate Director, Regulatory Affairs

argenx

Posted 5d ago

Remote

$164K - $226K

Full-time

Associate Director, Ethics & Compliance - Risk Assessment and Monitoring

argenx

Posted 6d ago

Remote

$172K - $237K

Full-time

Head of Health Economics & Outcomes Research (HEOR)

argenx

Posted 1w ago

Remote

$328K - $451K

Full-time

Global Medical Safety Lead

argenx

Posted 1w ago

Remote

Full-time

FB102 Commercial Lead

argenx

Posted 1w ago

Remote

$152K - $287K

Full-time

Head of Data Strategy

argenx

Posted 1w ago

Remote

$236K - $325K

Full-time

Head of Commercial Analytics & Insights

argenx

Posted 1w ago

Remote

$236K - $325K

Full-time

Associate Director, US Patient Advocacy

argenx

Posted 1w ago

Remote

$164K - $226K

Full-time

Associate Director, Statistical Modeling and Simulation

argenx

Posted 2w ago

Gent, Belgium

Full-time

Field Clinical Educator, Pacific Northwest

argenx

Posted 2w ago

Portland, OR

Full-time

Senior Director, Commercialization Strategy & Operations Enablement

argenx

Posted 2w ago

Boston, MA, USA

$236K - $325K

Full-time

Project Toxicologist

argenx

Posted 2w ago

Gent, Belgium

Full-time

Associate Director Ethics & Compliance

argenx

Posted 2w ago

Remote

Full-time

Global DT Lead Development

argenx

Posted 3w ago

Remote

Full-time

Business Leader, Great Lakes (Michigan)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Market Head, South Central

argenx

Posted 3w ago

United States - Field

$236K - $325K

Full-time

Business Leader, Mid-Atlantic (Mid-Atlantic)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

1
2
3
4

Company Overview

Active Jobs

84

Pipeline Programs

88

Drug Products

2

Clinical Trials

98

View Full Company Profile

Therapeutic Areas

Neurology Immunology Oncology

Links

Company Website Careers Page

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteMedical AffairsImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteRegulatory AffairsImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteRegulatory AffairsImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteLegalImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteReal-World EvidenceImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteCommercialImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteBusiness DevelopmentImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteCommercialImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Business DevelopmentImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteLegalImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Next